Investigators presented positive data from the ENRICH trial showcasing the superiority of NICO Corporation’s technologies to standard of care for ICH.
NICO
Enriching results.
4.7MMedia Placement UVM
ENRICH, the first surgical trial for ICH to meet its primary safety and efficacy endpoints.
NICO Corporation, in partnership with Emory University, was set to announce the results of their seven year multi-site clinical trial (ENRICH) evaluating the surgical treatment of intracerebral hemorrhage (ICH) with NICO’s BrainPath and Myriad tools. The trial is the first surgical trial for ICH to meet its primary safety and efficacy endpoints.
30,000+Social Media Audience
786Press Pick-ups
70+Social Posts
01Strategy
Leverage the largest gathering of neurosurgeons (the Annual Meeting of the American Association of Neurological Surgeons) to drive awareness of the ENRICH results among NICO’s target audience, building momentum for the positive outcome data release, and emphasizing the scientific validation of NICO’s innovative technology and approach.
02Solution
Executed a targeted, multi-channel communications strategy, including conference presence and collaboration with trial investigators from Emory and the Cleveland Clinic, to ignite the conversation among key opinion leaders and position neurosurgeons as champions of NICO’s technology to improve patient outcomes in intracerebral hemorrhage (ICH).
03Execution
Created surround sound during the AANS meeting to amplify the ENRICH data including media materials and visuals that reinforced unmet needs and the positive data. Collaborated on booth theme and designed video content to generate excitement surrounding announcement and provided on-site support. Leveraged both organic and paid social content to drive awareness of ENRICH results and AANS presence.
Booth Experience
Earned Media
Clot Evacuation After ICH Tied to Better Outcome: ENRICH
